CureVac

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$2.47-$5.72
Market Cap
$1B
Shares Short
547,316

Financials

See more
Revenue (12 Mos)
$70.7M
Revenue Growth (YoY)
-89%
Gross Profit (12 Mos)
$65.9M
Diluted EPS
$0.67

News

See more

Yahoo Finance • last month

BioNTech Achieves Minimum Condition in CureVac Exchange Offer

Yahoo Finance • last month

BioNTech erfüllt Mindestannahmebedingungen im Rahmen des Umtauschangebots für CureVac-Aktien

Yahoo Finance • last month

BioNTech’s exchange offer for German mRNA vaccine peer CureVac set to expire Dec. 3

Yahoo Finance • last month

BioNTech Shares Progress on Exchange Offer for CureVac Shares and Highlights December 3, 2025, at 9:00 a.m. Eastern Time Expiration

About

CEO
Dr. Alexander Zehnder M.B.A., M.D.
CFO
Mr. Axel-Sven Malkomes
Address
Friedrich-Miescher-Strasse 15, Tübingen, Germany, 72076
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
825